Role of eNOS in neovascularization: NO for endothelial progenitor cells

Trends in Molecular Medicine

Volumn 10, Issue 4, 2004, Pages 143-145

  Duda, Dan G ^a   Fukumura, Dai ^a   Jain, Rakesh K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FLUOROURACIL; GELATINASE B; GROWTH FACTOR; INTERLEUKIN 8; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PLACENTAL DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; SCATTER FACTOR; SPHINGOSINE 1 PHOSPHATE; TRANSFORMING GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN E;

ANGIOGENESIS; ENDOTHELIUM CELL; ENZYME INHIBITION; GENE THERAPY; INFLAMMATION; ISCHEMIC HEART DISEASE; MALIGNANT NEOPLASTIC DISEASE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; STEM CELL; WOUND HEALING;

EID: 1642619061     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2004.02.001     Document Type: Short Survey

References (27)

1. Moncada S. The L-arginine: nitric oxide pathway. Acta Physiol. Scand. 145:1992;201-227.
2. Fukumura D., et al. Tumor induction of VEGF promoter activity in stromal cells. Cell. 94:1998;715-725.
3. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases: from genes to function to therapy. Nature. 407:2000;249-257.
4. Ferrara N., et al. The biology of VEGF and its receptors. Nat. Med. 9:2003;669-676.
5. Fulton D., et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature. 399:1999;597-601.
6. Govers R., Rabelink T.J. Cellular regulation of endothelial nitric oxide synthase. Am. J. Physiol. Renal Physiol. 280:2001;F193-F206.
7. Fukumura D., et al. Predominant role of endothelial nitric oxide synthase in vascular endothelail growth factor-induced angiogenesis and vascular permeability. Proc. Natl. Acad. Sci. U. S. A. 98:2001;2604-2609.
8. Gratton J.P., et al. Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice. Cancer Cell. 4:2003;31-39.
9. Calvi L.M., et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 425:2003;841-846.
10. Wagers A.J., et al. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science. 297:2002;2256-2259.
11. Isner J.M., et al. Bone marrow as a source of endothelial cells for natural and iatrogenic vascular repair. Ann. N Y Acad. Sci. 953:2001;75-84.
12. Rafii S., et al. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat. Rev. Cancer. 2:2002;826-835.
13. Ruzinova M.B., et al. Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. Cancer Cell. 4:2003;277-289.
14. Rabbany S.Y., et al. Molecular pathways regulating mobilization of marrow-derived stem cells for tissue revascularization. Trends Mol. Med. 9:2003;109-117.
15. Heissig B., et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell. 109:2002;625-637.
16. Larrivee B., et al. Vascular endothelial growth factor receptor-2 induces survival of hematopoietic progenitor cells. J. Biol. Chem. 278:2003;22006-22013.
17. Gerber H.P., et al. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature. 417:2002;954-958.
18. Luttun A., et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat. Med. 8:2002;831-840.
19. Hattori K., et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat. Med. 8:2002;841-849.
20. Hiratsuka S., et al. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell. 2:2002;289-300.
21. Gu Z., et al. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science. 297:2002;1186-1190.
22. Aicher A., et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat. Med. 9:2003;1370-1376.
23. Murohara T., et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J. Clin. Invest. 101:1998;2567-2578.
24. Jain R.K., Duda D.G. Role of bone marrow-derived cells in tumor angiogenesis and treatment. Cancer Cell. 3:2003;515-516.
25. Hamano Y., et al. Physiological levels of tumstatin, a fragment of collagen IV α3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via αV β3 integrin. Cancer Cell. 3:2003;589-601.
26. Namba T., et al. Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model. Circulation. 108:2003;2250-2257.
27. Jain R.K. Molecular regulation of vessel maturation. Nat. Med. 9:2003;685-693.